Yushi Naito

5PUBLICATIONS
7CO-AUTHORS
PharmacogenomicsCancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 29, 2026
Baseline Detrusor Overactivity Subtype and Impaired Detrusor Contractility Are Associated With Persistent Detrusor Overactivity After β3-Adrenoceptor Agonist Add-On Therapy in Men With Lower Urinary Tract Symptoms.

|Sep 20, 2023
Recent insights on the clinical, pathological, and molecular features of intraductal carcinoma of the prostate.

Yushi Naito, Masashi Kato, Jun Nagayama

|Nov 24, 2022
Clinical utility of intraductal carcinoma of the prostate in treatment selection for metastatic hormone-sensitive prostate cancer.

Yushi Naito, Masashi Kato, Hideji Kawanishi

|Sep 11, 2020
The clinical benefit of sequential therapy with androgen receptor axis-targeted agents alone in patients with castration-resistant prostate cancer: A propensity score-matched comparison study.

Yushi Naito, Masashi Kato, Hideji Kawanishi

Pageof 1

Frequent Collaborators

4 joint publications

Yoshihisa Matsukawa

3 joint publications

Masashi Kato

2 joint publications

Toyonori Tsuzuki

2 joint publications

Shohei Ishida